Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. FINASTERIDE MEVON 5MG TABLET [SIN13681P]

FINASTERIDE MEVON 5MG TABLET [SIN13681P]

Active ingredients: FINASTERIDE MEVON 5MG TABLET

Last updated 26 October 2025

Product Info

FINASTERIDE MEVON 5MG TABLET

[SIN13681P]

Product information

Active Ingredient and Strength

FINASTERIDE - 5 MG

Dosage Form

TABLET, FILM COATED

Manufacturer and Country

KLEVA PHARMACEUTICALS S.A. - GREECE

Registration Number

SIN13681P

Licence Holder

NOVEM PHARMA PRIVATE LIMITED

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

G04CB01

4.1 Therapeutic Indications
It is indicated for the treatment of benign prostatic hyperplasia (BPH) in patients with an enlarged prostate, since it reduces the prostate size, leading to improvement of the urinary flow rate and in BPH’s symptoms, it reduces the frequency of acute retention of urine and the need for surgical procedure for prostate transurethral resection and prostatectomy.

4.2 Dosage and mode of administration
The recommended dose is 5mg per day, with or without food.

Dosage in renal insufficiency
No dosage readjustment is required in patients with any degree of renal insufficiency (creatinine clearance as low as 9ml/min), and also no change was presented in the disposition of finasteride from pharmacokinetics studies.

Dosage in elderly patients
No dosage readjustment is required, although studies of pharmacokinetics show that the excretion of finasteride is slightly more reduced in patients aged above 70 years old.

Dosage in liver failure
There are no data for the administration of finasteride in patients with liver failure.

4.3 Contraindications
FINASTERIDE MEVON 5MG TABLET is contraindicated in women or children.
FINASTERIDE MEVON 5MG TABLET is contraindicated in the following cases:

  • Hypersensitivity in any component of the drug.

  • Pregnancy. Finasteride is contraindicated in women who are or may be pregnant (see 4.4. Special Warnings and Precautions during use. PRECAUTIONS, Pregnancy and Exposure to finasteride – danger to male fetus – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).